Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects
Adrian L. Lopresti, Sean Hood, Peter D. Drummond
Journal of Psychopharmacology (2012) Vol. 26, Iss. 12, pp. 1512-1524
Open Access | Times Cited: 142

Showing 1-25 of 142 citing articles:

Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications
Jennifer C. Felger, Frank Lotrich
Neuroscience (2013) Vol. 246, pp. 199-229
Open Access | Times Cited: 962
A review of lifestyle factors that contribute to important pathways associated with major depression: Diet, sleep and exercise
Adrian L. Lopresti, Sean Hood, Peter D. Drummond
Journal of Affective Disorders (2013) Vol. 148, Iss. 1, pp. 12-27
Closed Access | Times Cited: 572
Inflamed moods: A review of the interactions between inflammation and mood disorders
Joshua D. Rosenblat, S. Danielle, Rodrigo B. Mansur, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2014) Vol. 53, pp. 23-34
Closed Access | Times Cited: 553
A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers
Adrian L. Lopresti, Garth Maker, Sean Hood, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2013) Vol. 48, pp. 102-111
Closed Access | Times Cited: 336
Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability
Jiabei Sun, Chao Bi, Hok Man Chan, et al.
Colloids and Surfaces B Biointerfaces (2013) Vol. 111, pp. 367-375
Closed Access | Times Cited: 255
Obesity and psychiatric disorders: Commonalities in dysregulated biological pathways and their implications for treatment
Adrian L. Lopresti, Peter D. Drummond
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2013) Vol. 45, pp. 92-99
Closed Access | Times Cited: 214
SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury
Yang Yang, Weixun Duan, Yan Lin, et al.
Free Radical Biology and Medicine (2013) Vol. 65, pp. 667-679
Closed Access | Times Cited: 210
Icariin exerts an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation
Bo Liu, Chengyan Xu, Xiao Wu, et al.
Neuroscience (2015) Vol. 294, pp. 193-205
Closed Access | Times Cited: 190
Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study
Adrian L. Lopresti, Michaël Maes, Garth Maker, et al.
Journal of Affective Disorders (2014) Vol. 167, pp. 368-375
Closed Access | Times Cited: 188
Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
Seyed Ali Jazayeri-Tehrani, Seyed Mahdi Rezayat, Siavash Mansouri, et al.
Nutrition & Metabolism (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 163
Investigation of the Efficacy of Adjunctive Therapy with Bioavailability‐Boosted Curcuminoids in Major Depressive Disorder
Yunes Panahi, Roghayeh Badeli, Gholamreza Karami, et al.
Phytotherapy Research (2014) Vol. 29, Iss. 1, pp. 17-21
Closed Access | Times Cited: 155
Antidepressants for the treatment of depression in people with cancer
Giovanni Ostuzzi, Faith Matcham, Sarah Dauchy, et al.
Cochrane library (2015)
Open Access | Times Cited: 155
Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study
Adrian L. Lopresti, Peter D. Drummond
Journal of Affective Disorders (2016) Vol. 207, pp. 188-196
Closed Access | Times Cited: 148
Adaptive Cellular Stress Pathways as Therapeutic Targets of Dietary Phytochemicals: Focus on the Nervous System
Jaewon Lee, Dong‐Gyu Jo, Daeui Park, et al.
Pharmacological Reviews (2014) Vol. 66, Iss. 3, pp. 815-868
Open Access | Times Cited: 143
Antidepressants for the treatment of depression in people with cancer
Giovanni Ostuzzi, Faith Matcham, Sarah Dauchy, et al.
Cochrane library (2018) Vol. 2018, Iss. 4
Open Access | Times Cited: 136
Effect of curcumin on diabetic peripheral neuropathic pain: Possible involvement of opioid system
Hamid Reza Banafshe, Gholam Ali Hamidi, Mahdi Noureddini, et al.
European Journal of Pharmacology (2013) Vol. 723, pp. 202-206
Closed Access | Times Cited: 114
Effects of curcumin on chronic, unpredictable, mild, stress-induced depressive-like behaviour and structural plasticity in the lateral amygdala of rats
Lin Zhang, Junxia Luo, Minghua Zhang, et al.
The International Journal of Neuropsychopharmacology (2014) Vol. 17, Iss. 05, pp. 793-806
Closed Access | Times Cited: 109
Mapping inflammation onto mood: Inflammatory mediators of anhedonia
Walter Swardfager, Joshua D. Rosenblat, Meriem Benlamri, et al.
Neuroscience & Biobehavioral Reviews (2016) Vol. 64, pp. 148-166
Closed Access | Times Cited: 109
Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part II – contemporary contextual research
Alison C. Bested, Alan Logan, Eva M Selhub
Gut Pathogens (2013) Vol. 5, Iss. 1
Open Access | Times Cited: 106
Pharmacological Applications of Antioxidants: Lights and Shadows
Luciano Saso, Omidreza Firuzi
Current Drug Targets (2014) Vol. 15, Iss. 13, pp. 1177-1199
Closed Access | Times Cited: 105
Cognitive Dysfunction in Depression – Pathophysiology and Novel Targets
André F. Carvalho, Kamilla Woznica Miskowiak, Thomas Hyphantis, et al.
CNS & Neurological Disorders - Drug Targets (2015) Vol. 13, Iss. 10, pp. 1819-1835
Closed Access | Times Cited: 102
Protective Effects of Curcumin Against Ischemia-Reperfusion Injury in the Nervous System
Kowsar Bavarsad, George E. Barreto, Mousa‐Al‐Reza Hadjzadeh, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 2, pp. 1391-1404
Closed Access | Times Cited: 101
Antidepressive effects of kaempferol mediated by reduction of oxidative stress, proinflammatory cytokines and up-regulation of AKT/β-catenin cascade
Wenqi Gao, Wei Wang, Peng Yan, et al.
Metabolic Brain Disease (2019) Vol. 34, Iss. 2, pp. 485-494
Closed Access | Times Cited: 88
Beneficial effects of nano‐curcumin supplement on depression and anxiety in diabetic patients with peripheral neuropathy: A randomized, double‐blind, placebo‐controlled clinical trial
Sara Asadi, Mohammad Saeed Gholami, Fereydoun Siassi, et al.
Phytotherapy Research (2019) Vol. 34, Iss. 4, pp. 896-903
Closed Access | Times Cited: 79
Links Between Gut Dysbiosis and Neurotransmitter Disturbance in Chronic Restraint Stress-Induced Depressive Behaviours: the Role of Inflammation
Hailong Yang, Mengmeng Li, Manfei Zhou, et al.
Inflammation (2021) Vol. 44, Iss. 6, pp. 2448-2462
Open Access | Times Cited: 63
Page 1 - Next Page

Scroll to top